Csongor Váróczy Department of Medical Chemistry, Faculty of Medicine University of Debrecen Biography Publications Institution JoVE Articles Csongor Váróczy has not added a biography. If you are Csongor Váróczy and would like to personalize this page please email our Author Liaison for assistance. Publications PARP14 Contributes to the Development of the Tumor-Associated Macrophage Phenotype International Journal of Molecular Sciences. Mar, 2024 | Pubmed ID: 38612413 Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery Isotta Sturniolo1,2, Csongor Váróczy1,3, Ákos Máté Bede1,3, Csaba Hegedűs1, Máté Á. Demény1,4, László Virág1,4 1Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 2Doctoral School of Molecular Medicine, University of Debrecen, 3National Academy of Scientist Education, 4HUN-REN-DE Cell Biology and Signaling Research Group JoVE 65922 Cancer Research High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds Eliza Guti*1,2, Ákos Máté Bede*1,3, Csongor Váróczy*1,3, Csaba Hegedűs1, Máté Á. Demény1,4, László Virág1,4 1Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 2Doctoral School of Molecular Medicine, University of Debrecen, 3National Academy of Scientist Education, University of Debrecen, 4ELKH-DE Cell Biology and Signaling Research Group JoVE 64485 Cancer Research
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery Isotta Sturniolo1,2, Csongor Váróczy1,3, Ákos Máté Bede1,3, Csaba Hegedűs1, Máté Á. Demény1,4, László Virág1,4 1Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 2Doctoral School of Molecular Medicine, University of Debrecen, 3National Academy of Scientist Education, 4HUN-REN-DE Cell Biology and Signaling Research Group JoVE 65922 Cancer Research
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds Eliza Guti*1,2, Ákos Máté Bede*1,3, Csongor Váróczy*1,3, Csaba Hegedűs1, Máté Á. Demény1,4, László Virág1,4 1Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 2Doctoral School of Molecular Medicine, University of Debrecen, 3National Academy of Scientist Education, University of Debrecen, 4ELKH-DE Cell Biology and Signaling Research Group JoVE 64485 Cancer Research